Market News
Stocks to Watch, July 11: Glenmark Pharma, HUL, TCS, IT stocks, Tata Elxsi, IREDA, Avenue Supermarts, and more
.png)
5 min read | Updated on July 11, 2025, 08:52 IST
SUMMARY
Stocks to Watch: Shares of TCS as well as entire IT pack will be in focus after the country's largest IT services company reported its June quarter (Q1 FY26) numbers last evening. TCS reported a net profit of ₹12,760 crore for the first quarter of the current financial year (Q1 FY26), registering an upside of 6% from ₹12,040 crore profit logged in the same period last year.
The GIFT NIFTY futures suggest that the NIFTY50 index will open 135 points lower. | Image: Shutterstock
On a sequential basis, TCS' net profit advanced 4.38% from ₹12,224 crore. The profit numbers were better than HSBC estimates, as analysts at the research firm were expecting the IT giant to report a net profit of ₹11,925 crore.
Nair, currently President, Beauty & Wellbeing, Unilever, has been appointed for a period of five years.
Nair replaces Rohit Jawa, who will step down as CEO and MD on July 31, 2025, to pursue the next chapter in his personal and professional journey, the FMCG major said in a statement.
Tata Elxsi: Tata Elxsi on Thursday, July 10, reported a net profit of ₹144.4 crore for the quarter ended June 30, 2025 (Q1 FY26), down 21.6% from ₹184.1 crore logged in the corresponding quarter of the previous fiscal year.
On a sequential basis, the numbers slipped 16.3% as the company reported a net profit of ₹172.42 crore in the March 2025 quarter (Q4 FY25).
Its revenue from operations came in at ₹892.09 crore, down 3.7% from ₹926.45 crore logged in the year-ago period. In the March 2025 quarter, the company reported revenue of ₹908.34 crore. This translates to a decline of 1.78% on a QoQ basis.
The company had posted a net profit of ₹384 crore in the quarter ended on June 30, 2024, a BSE filing showed.
However, the revenue from operations improved to ₹1,947 crore during the quarter against ₹1,510 crore logged in the year-ago period.
The total expense rose to ₹1,655 crore in the quarter from ₹1,034.96 crore seen in the same period a year ago.
Delhi-based PC Jeweller has a total of 52 showrooms, of which 49 are company-owned.
In a regulatory filing on Thursday, the company informed that the board approved raising of funds up to ₹500 crore by way of preferential allotment on a private placement basis.
DFPCL, along with its step-down subsidiary Performance Chemiserve Ltd (PCL), has entered into the agreement for a period of five years.
Under the terms of the agreement, Petronet LNG will regasify approximately 25 TBTUs (trillion British thermal units) of LNG annually, post an initial ramp-up period, primarily at its Dahej terminal, DFPCL said in a regulatory filing.
The regasified gas will be primarily supplied to the company and PCL's manufacturing facilities units at Taloja, Mumbai, for internal consumption, it said.
Under the terms of the agreement, IGI partners with AbbVie and grants exclusive rights to globally develop, manufacture, and commercialise ISB 2001 across North America, Europe, Japan, and Greater China.
Glenmark Pharmaceuticals will develop, manufacture and lead the commercialisation of ISB 2001 across emerging markets, including the rest of Asia, Latin America, the Russia/CIS region, the Middle East, Africa, Australia, New Zealand and South Korea.
About The Author
Next Story
